Frekidir

Frekidir is an oral medication containing sitagliptin, used to manage type 2 diabetes. It helps control blood sugar levels by enhancing insulin production.

Frekidir, containing sitagliptin, is primarily used to manage type 2 diabetes. It works by increasing insulin production in response to meals, helping to regulate blood sugar levels. This medication is often prescribed as part of a comprehensive diabetes management plan, which may include diet and exercise. Frekidir is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.

Common effects of Frekidir may include headache, nausea, and diarrhea. Some users might experience upper respiratory tract infections or joint pain. These effects are generally mild and temporary, but if they persist or worsen, it is advisable to consult a healthcare professional.

Frekidir should be handled with care, especially by individuals with a history of kidney problems, pancreatitis, or severe gastrointestinal issues. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Keep the medication out of reach of children and store it as directed.

Frekidir may interact with certain medications, including insulin and other diabetes drugs. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be moderated, as it can affect blood sugar levels and overall health.